Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment

Gianluca Quaglio, Fabio Lugoboni, Cristian Pattaro, Barbara Melara, Paolo Mezzelani, Don Des Jarlais

Research output: Contribution to journalArticle

Abstract

Erectile dysfunction (ED) is common among people in treatment for heroin addiction. The purpose of the study was to examine the frequency of ED among methadone and buprenorphine maintenance therapy patients, and to identify factors associated with ED. Patients - recruited from 7 centres in Italy - underwent: (i) a structured interview on socio-demographic characteristics, drug use and sexual behaviour; (ii) IIEF-15 test, a test of sexual function; (iii) Zung test for depression. The study included 201 males: 42% were on methadone maintenance, 58% were on buprenorphine. Overall, 58% reported no ED, 24% reported mild to moderate ED, and 18% severe ED. In univariate analysis buprenorphine patients had less ED than methadone patients (p = 0.0135). Subjects living with a partner had less ED than others (p = 0.0018). More depressed subjects had more ED (p < 0.001). Heterosexual patients reported less ED than homo/bisexual patients (p = 0.0427), and partner's use of heroin was associated with more ED (p = 0.0078). The significant univariate predictors were entered into a cumulative logit model. Living with a sexual partner was associated with a lower likelihood of ED, while depression, having a sexual partner with a history of drug use and not having a steady partner were associated with a greater likelihood of ED. The significant association between treatment and ED which appeared in univariate analysis (with buprenorphine patients reporting less ED than methadone patients) was not confirmed by the multivariate analysis. Both psychological and social factors were associated with ED which is an important problem for many males in methadone and buprenorphine treatment.

Original languageEnglish (US)
Pages (from-to)12-18
Number of pages7
JournalDrug and Alcohol Dependence
Volume94
Issue number1-3
DOIs
StatePublished - Apr 1 2008

Fingerprint

Buprenorphine
Methadone
Heroin
Erectile Dysfunction
Therapeutics
Pharmaceutical Preparations
Sexual Partners
Depression
Heroin Dependence
Heterosexuality

Keywords

  • Buprenorphine
  • Erectile dysfunction
  • Methadone
  • Prevalence

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. / Quaglio, Gianluca; Lugoboni, Fabio; Pattaro, Cristian; Melara, Barbara; Mezzelani, Paolo; Des Jarlais, Don.

In: Drug and Alcohol Dependence, Vol. 94, No. 1-3, 01.04.2008, p. 12-18.

Research output: Contribution to journalArticle

Quaglio, Gianluca ; Lugoboni, Fabio ; Pattaro, Cristian ; Melara, Barbara ; Mezzelani, Paolo ; Des Jarlais, Don. / Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. In: Drug and Alcohol Dependence. 2008 ; Vol. 94, No. 1-3. pp. 12-18.
@article{f3dc5f34201842af9e76e0878546500d,
title = "Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment",
abstract = "Erectile dysfunction (ED) is common among people in treatment for heroin addiction. The purpose of the study was to examine the frequency of ED among methadone and buprenorphine maintenance therapy patients, and to identify factors associated with ED. Patients - recruited from 7 centres in Italy - underwent: (i) a structured interview on socio-demographic characteristics, drug use and sexual behaviour; (ii) IIEF-15 test, a test of sexual function; (iii) Zung test for depression. The study included 201 males: 42{\%} were on methadone maintenance, 58{\%} were on buprenorphine. Overall, 58{\%} reported no ED, 24{\%} reported mild to moderate ED, and 18{\%} severe ED. In univariate analysis buprenorphine patients had less ED than methadone patients (p = 0.0135). Subjects living with a partner had less ED than others (p = 0.0018). More depressed subjects had more ED (p < 0.001). Heterosexual patients reported less ED than homo/bisexual patients (p = 0.0427), and partner's use of heroin was associated with more ED (p = 0.0078). The significant univariate predictors were entered into a cumulative logit model. Living with a sexual partner was associated with a lower likelihood of ED, while depression, having a sexual partner with a history of drug use and not having a steady partner were associated with a greater likelihood of ED. The significant association between treatment and ED which appeared in univariate analysis (with buprenorphine patients reporting less ED than methadone patients) was not confirmed by the multivariate analysis. Both psychological and social factors were associated with ED which is an important problem for many males in methadone and buprenorphine treatment.",
keywords = "Buprenorphine, Erectile dysfunction, Methadone, Prevalence",
author = "Gianluca Quaglio and Fabio Lugoboni and Cristian Pattaro and Barbara Melara and Paolo Mezzelani and {Des Jarlais}, Don",
year = "2008",
month = "4",
day = "1",
doi = "10.1016/j.drugalcdep.2007.09.025",
language = "English (US)",
volume = "94",
pages = "12--18",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1-3",

}

TY - JOUR

T1 - Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment

AU - Quaglio, Gianluca

AU - Lugoboni, Fabio

AU - Pattaro, Cristian

AU - Melara, Barbara

AU - Mezzelani, Paolo

AU - Des Jarlais, Don

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Erectile dysfunction (ED) is common among people in treatment for heroin addiction. The purpose of the study was to examine the frequency of ED among methadone and buprenorphine maintenance therapy patients, and to identify factors associated with ED. Patients - recruited from 7 centres in Italy - underwent: (i) a structured interview on socio-demographic characteristics, drug use and sexual behaviour; (ii) IIEF-15 test, a test of sexual function; (iii) Zung test for depression. The study included 201 males: 42% were on methadone maintenance, 58% were on buprenorphine. Overall, 58% reported no ED, 24% reported mild to moderate ED, and 18% severe ED. In univariate analysis buprenorphine patients had less ED than methadone patients (p = 0.0135). Subjects living with a partner had less ED than others (p = 0.0018). More depressed subjects had more ED (p < 0.001). Heterosexual patients reported less ED than homo/bisexual patients (p = 0.0427), and partner's use of heroin was associated with more ED (p = 0.0078). The significant univariate predictors were entered into a cumulative logit model. Living with a sexual partner was associated with a lower likelihood of ED, while depression, having a sexual partner with a history of drug use and not having a steady partner were associated with a greater likelihood of ED. The significant association between treatment and ED which appeared in univariate analysis (with buprenorphine patients reporting less ED than methadone patients) was not confirmed by the multivariate analysis. Both psychological and social factors were associated with ED which is an important problem for many males in methadone and buprenorphine treatment.

AB - Erectile dysfunction (ED) is common among people in treatment for heroin addiction. The purpose of the study was to examine the frequency of ED among methadone and buprenorphine maintenance therapy patients, and to identify factors associated with ED. Patients - recruited from 7 centres in Italy - underwent: (i) a structured interview on socio-demographic characteristics, drug use and sexual behaviour; (ii) IIEF-15 test, a test of sexual function; (iii) Zung test for depression. The study included 201 males: 42% were on methadone maintenance, 58% were on buprenorphine. Overall, 58% reported no ED, 24% reported mild to moderate ED, and 18% severe ED. In univariate analysis buprenorphine patients had less ED than methadone patients (p = 0.0135). Subjects living with a partner had less ED than others (p = 0.0018). More depressed subjects had more ED (p < 0.001). Heterosexual patients reported less ED than homo/bisexual patients (p = 0.0427), and partner's use of heroin was associated with more ED (p = 0.0078). The significant univariate predictors were entered into a cumulative logit model. Living with a sexual partner was associated with a lower likelihood of ED, while depression, having a sexual partner with a history of drug use and not having a steady partner were associated with a greater likelihood of ED. The significant association between treatment and ED which appeared in univariate analysis (with buprenorphine patients reporting less ED than methadone patients) was not confirmed by the multivariate analysis. Both psychological and social factors were associated with ED which is an important problem for many males in methadone and buprenorphine treatment.

KW - Buprenorphine

KW - Erectile dysfunction

KW - Methadone

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=39149083075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149083075&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2007.09.025

DO - 10.1016/j.drugalcdep.2007.09.025

M3 - Article

VL - 94

SP - 12

EP - 18

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1-3

ER -